Harbor BioSciences (HRBR) AI Stock Analysis

19 Followers

Harbor BioSciences

(Other OTC:HRBR)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Negative Factors

Harbor BioSciences (HRBR) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $141.40M
Dividend Yield: ―
Average Volume (3M): 11.11K
Price to Earnings (P/E): -8.6
Beta (1Y): 20.49
Revenue Growth: -67.05%
EPS Growth: ―
Country: US
Employees: 233
Sector: Industrials
Sector Strength: 63
Industry: Airlines, Airports & Air Services

Harbor BioSciences Business Overview & Revenue Model

Company Description

Harbor Diversified, Inc. provides regional air services in the United States. The company leases flight equipment; and provides flight equipment financing. As of December 31, 2023, it owned and operated a fleet of 63 regional jets. Harbor Diversified...

Harbor BioSciences Risk Analysis

Harbor BioSciences disclosed 25 risk factors in its most recent earnings report. Harbor BioSciences reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks

1.Air Wisconsin may not be able to achieve positive cash flows from operations and may need to seek to obtain additional financing.Q3, 2024

2.Each of our proposed new business strategies has significant risks and uncertainties, and, if we are unable to respond adequately to these risks, Air Wisconsin may be unable to achieve or sustain profitability or generate positive cash flows from operations, which would have an adverse impact on our financial condition and results of operations.Q3, 2024

3.We have identified a material weakness in our internal control over financial reporting, which could, if not effectively remediated, result in additional restatements of our financial statements, and a failure to meet our reporting and financial obligations, each of which could adversely affect our results of operations and financial condition.Q4, 2023

Harbor BioSciences Peers Comparison

Overall Rating

UnderperformOutperform

Sector (63)

Financial Indicators

HRBR against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SRTA	66Neutral	$537.71M	-20.67	-8.86%	―	22.73%	3.40%
Sector *	63Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%

* Industrials Sector Average

Performance Comparison

HRBR and its peers over the selected period
Show on chart	Ticker	Company Name	Price	Change	% Change
	HRBR	Harbor BioSciences	2.42	1.47	154.74%
	SRTA	Strata Critical Medical, Inc.	6.01	1.12	22.90%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Harbor BioSciences AI Stock Analysis